CYTO (Altamira Therapeutics) Kacepetan wutah bathi saben saham ing taun lumaku
The absence of commercial products and rising R&D costs drive current dynamics, resulting in the annual earnings per share growth metric stalling at 64.80. This is driven by Altamira Therapeutics (CYTO) pursuing leadership in RNA therapy via peptide cell delivery. Scaling potential is based on strategic alliances and the integration of the Peptide+ IT platform into partner formulas.
Rincian metrik komprehensif lan analitis altamiratherapeutics.com (CYTO)
- rega saham lan target rega konsensus:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- rincian utang lan likuiditas:
Utang marang Ekuitas Altamira Therapeutics|CYTO - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka cendhak marang modal Altamira Therapeutics Ltd.|CYTO - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Altamira Therapeutics|CYTO - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Altamira Therapeutics|Koefisien jangkoan perantara altamiratherapeutics.com
- indikator pendapatan resik lan kelipatan nilai:
CYTO - Bathi resik perusahaan|Penghasilan resik sing dikarepake Altamira Therapeutics|CYTO - Pangali P/E|Pangali Forward P/E Altamira Therapeutics Ltd.|CYTO - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Altamira Therapeutics|CYTO - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone patang kuartal pungkasan Altamira Therapeutics|CYTO - Bathi resik saben saham (EPS TTM)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan altamiratherapeutics.com|CYTO - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Altamira Therapeutics
- informasi babagan volume dodolan lan pendapatan:
Pambiji fundamental:Altamira Therapeutics
This metric measures the dynamics of net earnings per share, reflecting the rate of capital recovery relative to the previous year. Analyzing year-over-year EPS growth percentages allows for the differentiation of sustainable business strengthening from random volatile spikes. For Altamira Therapeutics (CYTO), such a metric is critical, as it confirms the effectiveness of monetizing patent-protected nanotechnologies amidst costly clinical trials.
Pesaing utama
Haleon PLC - Tambahing bathi saben saham ing taun lumaku|KVUE (Kenvue Corp) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Verona Pharma Inc. VRNA|Wutah bathi saben saham ing taun lumaku Jyong Biotech Ltd (MENS)|LGND (ligand.com) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku AMRX (Amneal)|Wutah bathi ing taun lumaku Perrigo Company PLC PRGO|ALVO - Wutah bathi saben saham ing taun lumaku|LQDA: Wutah bathi saben saham ing taun lumaku|GLPG (Galapagos NV) - Wutah bathi resik saben saham ing taun iki|ANIP: Wutah bathi resik saben siji saham kanggo taun lumaku|MNKD (MannKind) - Wutah bathi ing taun lumaku|Wutah bathi ing taun lumaku Amphastar Pharmaceuticals Inc|Wutah bathi saben saham ing taun lumaku Pacira (PCRX)|Wutah bathi resik saben saham ing taun iki ARS Corp SPRY|Wutah bathi ing taun lumaku TBPH (Theravance Biopharma)|Prakiraan wutah bathi resik saben saham ing taun iki aquestive.com (AQST)|SCPH - Wutah bathi saben saham ing taun lumaku|Tambahing bathi saben saham ing taun lumaku TECX (Tectonic Therapeutic, Inc.)|TNXP: Wutah bathi ing taun lumaku|China SXT Pharmaceuticals, Inc. (SXTC) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki EPRX|BHST: Tambahing bathi saben saham ing taun lumaku|Wutah bathi resik saben saham ing taun iki EXOZ (eXoZymes)|Wutah bathi resik saben siji saham kanggo taun lumaku ORMP|Wutah bathi ing taun lumaku ENTX (Entera Bio)|Tambahing bathi saben saham ing taun lumaku HYFT|ABVC BioPharma - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku cumberlandpharma.com|Quantum BioPharma (QNTM) - Wutah bathi saben saham ing taun lumaku|FibroGen Inc - Tambahing bathi saben saham ing taun lumaku|TELO (Telomir Pharma) - Wutah bathi ing taun lumaku|Wutah bathi ing taun lumaku Rani Therapeutics Inc|Wutah bathi saben saham ing taun lumaku Synergy CHC Corp (SNYR)|RLYB: Dinamika bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku LEXX (Lexaria Bioscience Corp.)|Pulmatrix Inc (PULM) - Kacepetan wutah bathi saben saham ing taun lumaku|PTHL: Wutah bathi resik saben saham ing taun iki|APM - Wutah bathi ing taun lumaku|LYRA (Lyra Therapeutics, Inc.) - Wutah bathi resik saben saham ing taun iki|IBO: Wutah bathi resik saben siji saham kanggo taun lumaku|TNFA (TNF Pharmaceuticals Inc.) - Wutah bathi ing taun lumaku|cbdMD Corp (YCBD) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi ing taun lumaku PRFX|Wutah bathi resik saben saham ing taun iki Lipella Pharma LIPO|Wutah bathi saben saham ing taun lumaku OptiNose, Inc. OPTN|Prakiraan wutah bathi resik saben saham ing taun iki pieris.com (PIRS)|Procaps - Wutah bathi ing taun lumaku|Petros Pharmaceuticals Inc (PTPI) - Wutah bathi resik saben saham ing taun iki|QLI (Qilian International Holding Group Limited) - Wutah bathi resik saben saham ing taun iki|Kacepetan wutah bathi saben saham ing taun lumaku ACELYRIN Inc. (SLRN)|Wutah bathi resik saben saham ing taun iki TFFP
